Cargando…
Co-treatment with disulfiram and glycyrrhizic acid suppresses the inflammatory response of chondrocytes
BACKGROUND: Osteoarthritis (OA) is a kind of systemic musculoskeletal disorder and a most important factor for causing disability and physical painfulness. Nevertheless, due to the fact that OA can be triggered by multiple etiological factors, this disease is hard to be cured. Therefore, it is of gr...
Autores principales: | Li, Chao, Li, Li, Lan, Tian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879531/ https://www.ncbi.nlm.nih.gov/pubmed/33579316 http://dx.doi.org/10.1186/s13018-021-02262-3 |
Ejemplares similares
-
Glycyrrhizic acid nanoparticles inhibit LPS-induced inflammatory mediators in 264.7 mouse macrophages compared with unprocessed glycyrrhizic acid
por: Wang, Wei, et al.
Publicado: (2013) -
Glycyrrhizic Acid in the Treatment of Liver Diseases: Literature Review
por: Li, Jian-yuan, et al.
Publicado: (2014) -
Extraction of Glycyrrhizic Acid and Glabridin from Licorice
por: Tian, Minglei, et al.
Publicado: (2008) -
Application of Disulfiram and its Metabolites in Treatment of Inflammatory Disorders
por: Guo, Wenyi, et al.
Publicado: (2022) -
Advances in the roles of glycyrrhizic acid in cancer therapy
por: Zhang, Yuqian, et al.
Publicado: (2023)